← Leaderboards
Anuradha Banerjee
University Of California San Francisco
$92,035
Attributed
$92,035
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$92,035 · 5
By mechanism
M01$92,035 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- Kevin M Shannon$44,683,939
- Diane W. Wara$7,985,315
- Jeffrey R Fineman$18,796,963
- Melvin B. Heyman$7,841,306
Others in their field
Top investigators on “Pediatric Neoplasm /Cancer”
- Gregory H Reaman · National Childhood Cancer Foundation$143,691,240
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$22,909,759
- Leland H Hartwell · Fred Hutchinson Cancer Research Center$22,238,492
- W. Archie Bleyer · National Childhood Cancer Foundation$13,947,311
- Richard Sposto · Epicenter Software$12,526,922
- Cheryl L Willman · University Of New Mexico$11,717,785
Research focus
Pediatric Neoplasm /CancerNeoplasm /Cancer ChemotherapyPatient Oriented ResearchClinical ResearchHuman SubjectHuman Therapy EvaluationAntineoplasticsDrug Screening /EvaluationClinical Trial Phase IBrain NeoplasmsChildrenPharmacokineticsDosageChild (0-11)Clinical Trial Phase IiAdolescence (12-20)PeptidesTemozolomideAngiogenesis InhibitorsAstrocytomaCell Adhesion MoleculesColony Stimulating FactorCombination Cancer TherapyCombination Chemotherapy
Grant awards (9)
PBTC005: PHASE I TRIAL OF TEMOZOLOMIDE AND O6-BENZYLGUANINE$38,531
M01 · FY2005 · RR
PHASE I/II TRIAL OF ZD1839 AND RADIATION IN PEDIATRIC PATIENTS WITH BRAIN TUMORS$14,311
M01 · FY2005 · RR
PBTC 012: PHASE I CILENGITIDE IN PEDIATRIC PATIENTS WITH REFRACTORY BRAIN TUMORS$4,037
M01 · FY2005 · RR
PBTC010: PHASE II STUDY OF OXALIPLATIN IN CHILDREN WITH MEDULLOBLASTOMA$1,835
M01 · FY2005 · RR
Phase I/II trial of ZD1839 and radiation in pediatric patients with brain tumors$12,297
M01 · FY2004 · RR
PBC 003: Phase I trial of escalating oral doses of SCH66336 in pediatric patient$9,521
M01 · FY2004 · RR
PBTC 012: Phase I cilengitide in pediatric patients with refractory brain tumors$6,347
M01 · FY2004 · RR
PBTC005: Phase I trial of temozolomide and O6-benzylguanine$2,776
M01 · FY2004 · RR
PBTC010: Phase II study of oxaliplatin in children with medulloblastoma$2,380
M01 · FY2004 · RR